Tumor Ablation Market to Reach $2.6 Billion by 2027 | Lucrative Growth Potential in Currently Available Therapeutic Options, and High Demand for Minimally and Non-invasive Therapies

Tumor Ablation Market to Reach $2.6 Billion by 2027 | Lucrative Growth Potential in Currently Available Therapeutic Options, and High Demand for Minimally and Non-invasive Therapies

“Grand View Research, Inc. – Market Research And Consulting.”
According to report published by Grand View Research, The global tumor ablation market size was valued at USD 1.1 billion in 2019 and is anticipated to witness a CAGR of 11.2% over the forecast period

The global tumor ablation market size is anticipated to reach USD 2.6 billion by 2027, according to a new report by Grand View Research, Inc. The market is estimated to witness a healthy CAGR of 11.2% during the forecast period. Increasing incidence of cancer and high demand for effective treatment options are the major factors driving the market. According to Cancer Research U.K., the incidence rate of cancer is expected to grow by 62% from 2018 to 2040. Lung, breast, bowel, and prostate are the most common sites reported with cancer in 2018.

Increasing inclination towards minimally invasive procedures owing to the benefits such as speedy recovery, patient comfort, and shorter turnaround time are the factors expected to foster the demand for advanced tumor ablation techniques during the forecast period. Integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, MRI, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings. This is expected to significantly eliminate the cost to the patient including hospital stays.

Request a Sample Copy of the Global Tumor Ablation Market Research Report @ www.grandviewresearch.com/industry-analysis/tumor-ablation-market/request/rs1

Supportive government initiatives such as screening programs, awareness campaigns, and cancer schemes for various cancer types are expected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) has started offering lung cancer screening programs in some areas of England. Such initiatives are anticipated to escalate the need for cancer management in early cancer stages thereby facilitate the demand for tumor ablation therapy.

The rising demand for advanced medical technologies coupled with improving financing capabilities of healthcare facilities is expected to increase the demand for tumor ablation devices during the forecast period.

Japan tumor ablation market, by technology, 2016 - 2027 (USD Million)

Further key findings from the study suggest: 

  • Radiofrequency dominated the technology segment with more than 30.0% share in 2019 owing to prominent application in solid tumor removal
  • Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety
  • Tumor ablation in lung cancer treatment is anticipated to witness fastest growth over the forecast period
  • Sedentary lifestyle, increasing incidences of smoking, and rising air pollution are contributing to the growing prevalence of lung cancer
  • North America dominated the overall market owing to the factors such as increasing prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
  • Major players in the tumor ablation market include Galil Medical Inc.; Misonix Inc.; HealthTronics; AngioDynamics; Covidien; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical Inc.

Global tumor ablation market share, by treatment 2019 (%)

Have Any Query? Ask Our Experts @ www.grandviewresearch.com/inquiry/1570/ibb

Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region:

Tumor Ablation Technology Outlook (Volume, ‘000 Units; Revenue, USD Million, 2016 – 2027)

  • Radiofrequency
  • Microwave
  • Cryoablation
  • Irreversible Electroporation
  • Other Ablation Technologies

Tumor Ablation Treatment Outlook (Volume, ‘000 Units; Revenue, USD Million, 2016 – 2027)

  • Surgical
    • Kidney Cancer
    • Liver Cancer
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Other Cancers
  • Laparoscopic
    • Kidney Cancer
    • Liver Cancer
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Other Cancers
  • Percutaneous
    • Kidney Cancer
    • Liver Cancer
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Other Cancers

Tumor Ablation Application Outlook (Revenue, USD Million, 2016 – 2027)

  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers

Tumor Ablation Regional Outlook (Revenue, USD Million, 2016 – 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Netherland
    • Switzerland
    • Belgium
    • Hungary
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Taiwan
    • Singapore
    • Malaysia
    • Indonesia
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Israel

Browse Related Report:

MRI-guided Neurosurgical Ablation Market: www.grandviewresearch.com/industry-analysis/mri-guided-neurosurgical-ablation-market

Radiofrequency Ablation Devices Market: www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/tumor-ablation-market